Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 527019, 7 pages
http://dx.doi.org/10.1155/2015/527019
Research Article

Effects of RuPeng15 Powder (RPP15) on Monosodium Urate Crystal-Induced Gouty Arthritis in Rats

1Pharmacology Department, Medical College, Qinghai University, China
2Pharmacy Department, Qinghai Red Cross Hospital, Xining 810000, China
3Gastroenterology Department, Qinghai Red Cross Hospital, Xining 810000, China

Received 18 January 2015; Revised 10 June 2015; Accepted 14 June 2015

Academic Editor: Gabino Garrido

Copyright © 2015 Y.-Y. Kou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Tramontini, C. Huber, R. Liu-Bryan, R. A. Terkeltaub, and K. S. Kilgore, “Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis,” Arthritis & Rheumatism, vol. 50, no. 8, pp. 2633–2639, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. R. C. Landis and D. O. Haskard, “Pathogenesis of crystal-induced inflammation,” Current Rheumatology Reports, vol. 3, no. 1, pp. 36–41, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. B. N. Cronstein and P. Sunkureddi, “Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis,” Journal of Clinical Rheumatology, vol. 19, no. 1, pp. 19–29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Neogi, “Clinical practice. Gout,” The New England Journal of Medicine, vol. 364, no. 5, pp. 443–452, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Nishimura, T. Akahoshi, M. Takahashi et al., “Attenuation of monosodium urate crystal-induced arthritis in rabbits by a neutralizing antibody against interleukin-8,” Journal of Leukocyte Biology, vol. 62, no. 4, pp. 444–449, 1997. View at Google Scholar · View at Scopus
  6. S. J. Getting, H. C. Christian, R. J. Flower, and M. Perretti, “Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis,” Arthritis & Rheumatism, vol. 46, no. 10, pp. 2765–2775, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. F. S. di Giovine, S. E. Malawista, E. Thornton, and G. W. Duff, “Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells: cytokine mRNA and protein kinetics, and cellular distribution,” Journal of Clinical Investigation, vol. 87, no. 4, pp. 1375–1381, 1991. View at Publisher · View at Google Scholar · View at Scopus
  8. H. K. Choi, D. B. Mount, and A. M. Reginato, “Pathogenesis of Gout,” Annals of Internal Medicine, vol. 143, no. 7, pp. 499–516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. W. J. Martin, M. Walton, and J. Harper, “Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout,” Arthritis & Rheumatism, vol. 60, no. 1, pp. 281–289, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Schiltz, F. Lioté, F. Prudhommeaux et al., “Monosodium urate monohydrate crystal-induced inflammation in vivo: quantitative histomorphometric analysis of cellular events,” Arthritis and Rheumatism, vol. 46, no. 6, pp. 1643–1650, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. J. F. Baker and H. Ralph Schumacher, “Update on gout and hyperuricemia,” International Journal of Clinical Practice, vol. 64, no. 3, pp. 371–377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Neogi, “Clinical practice: gout,” The New England Journal of Medicine, vol. 364, no. 5, pp. 443–452, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. E. B. Gonzalez, “An update on the pathology and clinical management of gouty arthritis,” Clinical Rheumatology, vol. 31, no. 1, pp. 13–21, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Zhang, M. Doherty, T. Bardin et al., “EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT),” Annals of the Rheumatic Diseases, vol. 65, no. 10, pp. 1312–1324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Jiang, X.-Y. You, K.-L. Fu, and W.-L. Yin, “Effects of extract from Mangifera indica leaf on monosodium urate crystal-induced gouty arthritis in rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 967573, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. M. Jung, H. R. Schumacher, H. Kim, M. Kim, S. H. Lee, and F. Pessler, “Reduction of urate crystal-induced inflammation by root extracts from traditional oriental medicinal plants: elevation of prostaglandin D2 levels,” Arthritis Research and Therapy, vol. 9, no. 4, article R64, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H. C. Wu and W. Mingshan, Common Tibetan Medicine, Qing Hai Peoples Publishing House, Qinghai, China, 2002.
  18. Y. Y. Gönpo, The Four Medical Tantras, People's Medical Publishing House, Beijing, China, 1983.
  19. W. Jiacuo and G. Zhu, Tibetan Notes, National Publishing House, Beijing, China, 2002.
  20. C.-L. Qing, “Clinical observation on 100 cases of Tibetan medicine of the pill of RuPeng15 on the treatment of rheumatoid arthritis,” Anthology of Medicine, vol. 22, no. 6, pp. 900–901, 2003. View at Google Scholar
  21. J.-G. Zang and Y. Ma, “Observation on the clinical effect of Tibetan medicine in the treatment of gouty arthritis,” Asia-Pacific Traditional Medicine, vol. 12, pp. 41–43, 2006. View at Google Scholar
  22. Y. Y. Kou, Y. F. Li, M. Yang, and R. L. Li, “Anti-inflammatory and antinociceptive effect of Tibetean medicine of Rupeng15 Powder (RPP15),” Chinese Traditional Patent Medicine, vol. 36, no. 10, pp. 2203–2205, 2014. View at Google Scholar
  23. L. Cavagna and W. J. Taylor, “The emerging role of biotechnological drugs in the treatment of gout,” BioMed Research International, vol. 2014, Article ID 264859, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Liu, X.-M. Zhang, and Y.-L. Wang, “Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling,” Journal of Nephrology, vol. 10, pp. 1007–1012, 2014. View at Google Scholar
  25. L. Liu and Y.-H. Wu, “Analysis of related factors of serum uric acid level and hyperuricemia on Tibetan and Han nationality populations in plain area,” Journal of Sichuan University, vol. 44, no. 5, pp. 847–849, 2013. View at Google Scholar
  26. P. Roberti di Sarsina, L. Ottaviani, and J. Mella, “Tibetan medicine: a unique heritage of person-centered medicine,” EPMA Journal, vol. 2, no. 4, pp. 385–389, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. J. Geng, Z. C. Ga, and Z. D. Z. H. Ga, “Tibetan medicine treatment on gout,” China National Medical Journal, vol. 9, pp. 16–17, 2012. View at Google Scholar
  28. S. J. Getting, R. J. Flower, L. Parente et al., “Molecular determinants of monosodium urate crystal-induced murine peritonitis: a role for endogenous mast cells and a distinct requirement for endothelial-derived selectins,” Journal of Pharmacology and Experimental Therapeutics, vol. 283, no. 1, pp. 123–130, 1997. View at Google Scholar · View at Scopus
  29. P. P. Tak and G. S. Firestein, “NF-κB: a key role in inflammatory diseases,” The Journal of Clinical Investigation, vol. 107, no. 1, pp. 7–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. K. N. Majumdar, A. Banerjee, and J. Ratha, “Leishmanial lipid suppresses tumor necrosis factor α, interleukin-1β, and nitric oxide production by adherent synovial fluid mononuclear cells in rheumatoid arthritis patients and induces apoptosis through the mitochondrial-mediated pathway,” Arthritis & Rheumatism, vol. 58, no. 3, pp. 696–706, 2008. View at Google Scholar
  31. Y. Si, Y. Zhang, J. Zhao et al., “Niacin inhibits vascular inflammation via downregulating nuclear transcription factor-κB signaling pathway,” Mediators of Inflammation, vol. 2014, Article ID 263786, 12 pages, 2014. View at Publisher · View at Google Scholar
  32. M. S. Islam, H. Yoshida, N. Matsuki et al., “Antioxidant, free radical-scavenging, and NF-κB-inhibitory activities of phytosteryl ferulates: structure-activity studies,” Journal of Pharmacological Sciences, vol. 111, no. 4, pp. 328–337, 2009. View at Publisher · View at Google Scholar · View at Scopus